These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31198824)

  • 1. Longitudinal small and medium enterprise (SME) data on survival, research and development (R&D) investment, and patent applications in Korea's innovation clusters from 2008 to 2014.
    Kim BK; Hwang J
    Data Brief; 2019 Aug; 25():103967. PubMed ID: 31198824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can rising labor costs boost private sector R&D investment? : Evidence from a survey of Chinese private firms.
    Deng C; Liu Y; Gu D
    PLoS One; 2022; 17(8):e0268287. PubMed ID: 35925924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis on Time-Lag Effect of Research and Development Investment in the Pharmaceutical Industry in Korea.
    Lee M; Choi M
    Osong Public Health Res Perspect; 2015 Aug; 6(4):241-8. PubMed ID: 26473091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured mathematical modelling on innovation management in project-oriented small construction firms.
    Wang C; Tang Y; Mo Y; Huang MM; Abdul-Rahman H
    Heliyon; 2023 Feb; 9(2):e13386. PubMed ID: 36755599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Technological Acquisition and R&D Expenditure in Innovative Investment.
    Weiyu Z; Othman A; Guli T
    Front Psychol; 2022; 13():855295. PubMed ID: 35478744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A firm-level dataset for analyzing entry, exit, employment and R&D expenditures in the UK: 1997-2012.
    Ugur M; Trushin E; Solomon E
    Data Brief; 2016 Sep; 8():153-7. PubMed ID: 27294184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capital allocation efficiency, technological innovation and vehicle carbon emissions: Evidence from a panel threshold model of Chinese new energy vehicles enterprises.
    Zhao M; Sun T; Feng Q
    Sci Total Environ; 2021 Aug; 784():147104. PubMed ID: 33892319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation in industry and the diffusion of technology.
    Utterback JM
    Science; 1974 Feb; 183(4125):620-6. PubMed ID: 17778831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of direct and indirect impacts of a positive list system on pharmaceutical R&D investments.
    Han E; Kim TH; Jeung MJ; Lee EK
    Clin Ther; 2013 Jul; 35(7):941-9. PubMed ID: 23806327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status of Korea's Industry-Academia Cooperation in Materials and Future Policy Directions.
    Kim SS
    Adv Mater; 2023 Oct; 35(43):e2204879. PubMed ID: 36190165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea.
    Lee M
    Osong Public Health Res Perspect; 2015 Aug; 6(4):249-55. PubMed ID: 26473092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of collaborative innovation on ICT-based technological convergence: A patent-based analysis.
    Hwang I
    PLoS One; 2020; 15(2):e0228616. PubMed ID: 32017795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forms of extramural research acquisition and product innovation: Data from econometric estimations.
    Carboni OA; Medda G
    Data Brief; 2021 Dec; 39():107567. PubMed ID: 34825033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Blossom in Medical Care: The Influence of Big Data Platform on Medical Innovation.
    Liu B; Guo S; Ding B
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31947558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of product subsidies on R&D investment for new energy vehicle firms: Considering quality preference of the early adopter group.
    Meng W; Wang Y; Li Y; Huang B
    PLoS One; 2020; 15(7):e0236626. PubMed ID: 32735570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
    D'Este P; Tribó JA; García-Romero A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan.
    Hsieh CR; Löfgren H
    Aust Health Rev; 2009 May; 33(2):245-57. PubMed ID: 19563313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures.
    Lee M; Choi M
    Osong Public Health Res Perspect; 2015 Oct; 6(5):302-9. PubMed ID: 26730355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation drivers of external competitiveness in the great recession.
    Brancati E; Brancati R; Guarascio D; Zanfei A
    Small Bus Econ (Dordr); 2022; 58(3):1497-1516. PubMed ID: 38624443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. University-industry collaboration and firm innovation: an empirical study of the biopharmaceutical industry.
    Tian M; Su Y; Yang Z
    J Technol Transf; 2022; 47(5):1488-1505. PubMed ID: 34456468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.